Healthcare -
Biotechnology - NASDAQ - US
$ 8.885
-1.39 %
$ 1.42 B
Market Cap
-4.08
P/E
NVAX - TOTAL CURRENT LIABILITIES
Total Current Liabilities NVAX - Novavax, Inc.
1.64 B
LAST VALUE
-17.29%
2 YEAR CAGR
104.66%
5 YEAR CAGR
56.18%
10 YEAR CAGR